Literature DB >> 30272372

Identification of miRNA and mRNA expression profiles by PCR microarray in hepatitis B virus‑associated hepatocellular carcinoma.

Xiong-Wei Cui1, Zhi-Ling Qian1, Cong Li1, Shi-Chang Cui1.   

Abstract

The present study aimed to identify differentially expressed microRNAs (miRNAs) and mRNAs in hepatitis B virus‑associated hepatocellular carcinoma (HCC). A total of five HCC tissues and paired adjacent non‑tumor tissues were screened to identify the differentially expressed miRNAs and target mRNAs using polymerase chain reaction microarrays. The interaction between differential miRNA and mRNA expression was concurrently analyzed using bioinformatics methods. A total of 32 differentially expressed miRNAs (four upregulated miRNAs and 28 downregulated miRNAs) and 16 differentially expressed mRNAs (11 upregulated mRNAs and five downregulated mRNAs) were identified. Among these, upregulated hsa‑miRNA (miR)‑96‑5p and hsa‑miR‑18b‑5p suppressed their target mRNAs forkhead box O1 and MET transcriptional regulator MACC1 (MACC1). Downregulation of hsa‑miR‑199a‑5p led to upregulation of its target mRNAs, cyclin dependent kinase 4 and insulin like growth factor 2 (IGF2). The high‑level expression of IGF2 mRNA and cyclin E1 mRNA was due to the low‑level expression of hsa‑miR‑145‑5p, hsa‑miR‑181a‑5p, hsa‑miR‑199a‑5p and hsa‑miR‑223a‑3p, and hsa‑miR‑26a‑5p and hsa‑miR‑26b‑5p, respectively. The low‑level expression of coronin 1A mRNA and MACC1 mRNA was due to overexpression of hsa‑miR‑517a‑3p and hsa‑miR‑18a‑5p, and hsa‑miR‑18b‑5p, respectively. Numerous gene ontology terms were associated with oncogenesis. The most enriched pathways targeted by the dysregulated miRNAs and mRNAs were associated with cancer and oncogenesis pathways. The present data suggested that differential miRNA and mRNA expression is present in HCC. Thus, interactions between certain miRNAs and mRNAs may be involved in the pathogenesis of HCC.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30272372     DOI: 10.3892/mmr.2018.9516

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  6 in total

1.  A Simple Competing Endogenous RNA Network Identifies Novel mRNA, miRNA, and lncRNA Markers in Human Cholangiocarcinoma.

Authors:  Cheng Zhang; Chunlin Ge
Journal:  Biomed Res Int       Date:  2019-03-24       Impact factor: 3.411

Review 2.  Role of Non-Coding RNAs in the Progression of Liver Cancer: Evidence from Experimental Models.

Authors:  April O'Brien; Tianhao Zhou; Christopher Tan; Gianfranco Alpini; Shannon Glaser
Journal:  Cancers (Basel)       Date:  2019-10-25       Impact factor: 6.639

3.  Integrated analysis of ceRNA network in hepatocellular carcinoma using bioinformatics analysis.

Authors:  Yu Luo; Hongjuan Li; Hongli Huang; Lian Xue; Haiwen Li; Li Liu; Haiyan Fu
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

4.  Exosomal MicroRNAs as Potential Biomarkers of Hepatic Injury and Kidney Disease in Glycogen Storage Disease Type Ia Patients.

Authors:  Roberta Resaz; Davide Cangelosi; Daniela Segalerba; Martina Morini; Paolo Uva; Maria Carla Bosco; Giuseppe Banderali; Ana Estrella; Corbinian Wanner; David A Weinstein; Annalisa Sechi; Sabrina Paci; Daniela Melis; Maja Di Rocco; Young Mok Lee; Alessandra Eva
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

5.  Regulation of Tumorigenesis in Hepatocellular Carcinoma via the AKT3 Pathway in Cell Lines.

Authors:  Mingxuan Xing; Xinwei Xie; Zhi Liu; Xiaohong Du
Journal:  Comput Math Methods Med       Date:  2021-10-28       Impact factor: 2.238

6.  The pattern of gene copy number alteration (CNAs) in hepatocellular carcinoma: an in silico analysis.

Authors:  Arman Shahrisa; Maryam Tahmasebi-Birgani; Hossein Ansari; Zahra Mohammadi; Vinicio Carloni; Javad Mohammadi Asl
Journal:  Mol Cytogenet       Date:  2021-07-02       Impact factor: 2.009

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.